TTP Centenary – Webinar 5: Therapeutic Targets
Replay available
As we conclude our Thrombotic Thrombocytopenic Purpura (TTP) Centenary webinar series, don’t miss the final fifth session, where our experts will delve into the critical therapeutic targets. Discover the gold-standard treatments for both acquired and hereditary TTP, explore the latest advancements in patient care, and learn about promising future therapeutic strategies.
Join us to complete your TTP knowledge with this essential information.
ABOUT THE WEBINAR
LEARNING OUTCOMES
- Understand the standard of care for managing acquired and hereditary TTP.ç
- Discuss current and emerging developments in TTP management.
- Explore future drugs and therapeutic strategies for TTP patients.
TOPICS & SPEAKERS
A Standard of Care for the management of acquired TTP
Paul COPPO
Sorbonne University, Paris (FR)
A standard of care for the management of Hereditary TTP
X. LONG ZHENG
University of Kansas Medical Center, Kansa City (US)
Current and upcoming development in TTP management
Paul KNOEBL
Medical University of Vienna, Vienna (AT)
Future drugs and therapeutic strategies in patients with TTP
Flora PEYVANDI
Fondazione IRCCS CA’ Granda Ospedale Maggiore Policlinico, Milan (IT)
MODERATORS
Lara ZAFRANI
St-Louis University Hospital, Paris (FR)
María Eva MINGOT CASTELLANO
Virgen del Rocio University Hospital, Seville Institute of Biomedicine, Seville (SP)
Thanks to the support of
